Glucose-induced hyperkalemia in diabetic subjects

Area of Science:

• Endocrinology
• Metabolic Disorders
• Diabetes Mellitus Research

Background:

• Insulin deficiency in diabetes mellitus can impair glucose metabolism and electrolyte balance.
• The role of aldosterone in regulating potassium levels, particularly after glucose intake, requires further elucidation in diabetic patients.

Purpose of the Study:

• To investigate the incidence and mechanisms of glucose-induced hyperkalemia in insulin-deprived diabetic patients.
• To assess the relationship between plasma potassium, aldosterone levels, and oral glucose or potassium loads in this population.

Main Methods:

• Administered oral glucose (100 g) to four insulin-deprived diabetic patients with normal baseline potassium and aldosterone.
• Administered oral potassium chloride (50 mEq) to four other insulin-deprived diabetic patients.
• Investigated the effect of aminoglutethimide on aldosterone biosynthesis and plasma potassium levels after oral potassium loads.

Main Results:

• Oral glucose administration led to significant hyperkalemia (average increase of 1.3 mEq/L) in insulin-deprived diabetics, accompanied by increased plasma aldosterone.
• Diabetic patients showed normal plasma potassium and aldosterone responses to oral potassium chloride.
• Suppression of aldosterone biosynthesis with aminoglutethimide did not result in elevated plasma potassium after oral potassium loads.

Conclusions:

• Glucose-induced hyperkalemia is a notable occurrence in insulin-deprived diabetic patients.
• This hyperkalemia is generally not associated with hypoaldosteronism.
• Acute aldosterone responses to potassium loads may not be critical for preventing postprandial hyperkalemia in diabetics.